Bristol Myers Squibb· @bmsnews · X·· 25 天前AI 评分42
AI 导读
#MEDIA: 我们正在#MSToronto2026 上展示一项评估#CARTCellTherapy 治疗多发性硬化症(MS)的1期试验结果:https://bit.ly/47V3NqZ
正文
#MEDIA: We’re presenting results from a Phase 1 trial evaluating #CARTCellTherapy in multiple sclerosis (MS) at #MSToronto2026: https://bit.ly/47V3NqZ
来源:Bristol Myers Squibb · x.com